The Food and Drug Administration is warning weight loss hopefuls not to consume two kinds of plant-based alternatives to Ozempic, citing potentially deadly consequences.
The announcement, which urged consumers to practice caution when purchasing other “botanical weight loss products,” follows the recent hospitalization of a patient in Maryland who had consumed a product labeled as Nuez de la India.that he was “shocked that this mix-up could have happened.”
According to the Centers for Disease Control and Prevention, a 1-year-old child in New Jersey was alsoafter mistakenly consuming Eva Nutrition Mexican Tejocote Root, a weight loss supplement purchased by the child’s mother. On social media, plant-based alternatives to popular weight loss medications have also surfaced, despite experts’ skepticism about their efficacy.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA says common decongestants don't work: What to know ahead of cold and flu seasonA Food and Drug Administration advisory panel declared on Tuesday that a common oral decongestant, phenylephrine, is not effective in relieving a stuffy nose, leaving many consumers and pharmaceutical companies with questions heading into the cold and flu season.
Weiterlesen »
A popular nasal decongestant doesn't actually relieve congestion, FDA advisers sayThe FDA asked advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient were moved behind pharmacy counters.
Weiterlesen »
8 Popular Cold Meds at Risk of Being Banned After New FDA RulingFollowing a new FDA ruling about phenylephrine's effectiveness, several popular cold meds could be banned soon.
Weiterlesen »
Alnylam Pharmaceuticals shares fall after FDA advisers weigh in on heart-disease drugAlnylam Pharmaceuticals Inc. shares fell more than 8% premarket on Thursday after advisers to the U.S. Food and Drug Administration on Wednesday weighed the...
Weiterlesen »